Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Truax

Showing results (191-200 of 248) with videos related to

Pageof 25
Sort By:
Oncotarget|April 24, 2018
Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cellsMing-Bo Huang, Kyle E Giesler, Brooke M Katzman, et al.
Anticancer Research|January 2, 2010
Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumorsElizabeth Dugan, Roxanne Truax, Kellen L Meadows, et al.
The Journal of Clinical Psychiatry|May 1, 1983
Overview of clinically significant adverse reactions to bupropionJ Van Wyck Fleet, P J Manberg, L L Miller, et al.
Disability and Rehabilitation|January 16, 2023
Effect of aquatic exercise programs according to the International Classification of Functionality, Disability and Health domains in individuals with Parkinson's disease: a systematic review and meta-analysis with GRADE quality assessmentMarcos Paulo Braz de Oliveira, Carla Rigo Lima, Silvia Lanziotti Azevedo da Silva, et al.
BMC Neurology|April 12, 2023
The impact of the COVID-19 pandemic on neuropsychiatric and sleep disorders, and quality of life in individuals with neurodegenerative and demyelinating diseases: a systematic review and meta-analysis of observational studiesMarcos Paulo Braz de Oliveira, Ana Emilia Fonseca de Castro, Andressa Leticia Miri, et al.
Frontiers in Toxicology|May 19, 2022
Application of Defined Approaches for Skin Sensitization to Agrochemical ProductsJudy Strickland, James Truax, Marco Corvaro, et al.
Cancer Chemotherapy and Pharmacology|October 26, 2010
Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumorsCarlos Castaneda, Kellen L Meadows, Roxanne Truax, et al.
Applied in Vitro Toxicology|January 17, 2023
Application of Defined Approaches to Assess Skin Sensitization Potency of Isothiazolinone CompoundsJudy Strickland, David G Allen, Dori Germolec, et al.
The American Journal of Pathology|September 28, 2006
Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodiesDeepak M Sampathu, Manuela Neumann, Linda K Kwong, et al.
Journal of the American Heart Association|February 24, 2021
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID-19Rohan Khera, Callahan Clark, Yuan Lu, et al.
Pageof 25

Showing results (191-200 of 248) with videos related to

Sort By:
Pageof 25
Oncotarget|April 24, 2018
Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cellsMing-Bo Huang, Kyle E Giesler, Brooke M Katzman, et al.
Anticancer Research|January 2, 2010
Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumorsElizabeth Dugan, Roxanne Truax, Kellen L Meadows, et al.
The Journal of Clinical Psychiatry|May 1, 1983
Overview of clinically significant adverse reactions to bupropionJ Van Wyck Fleet, P J Manberg, L L Miller, et al.
Disability and Rehabilitation|January 16, 2023
Effect of aquatic exercise programs according to the International Classification of Functionality, Disability and Health domains in individuals with Parkinson's disease: a systematic review and meta-analysis with GRADE quality assessmentMarcos Paulo Braz de Oliveira, Carla Rigo Lima, Silvia Lanziotti Azevedo da Silva, et al.
BMC Neurology|April 12, 2023
The impact of the COVID-19 pandemic on neuropsychiatric and sleep disorders, and quality of life in individuals with neurodegenerative and demyelinating diseases: a systematic review and meta-analysis of observational studiesMarcos Paulo Braz de Oliveira, Ana Emilia Fonseca de Castro, Andressa Leticia Miri, et al.
Frontiers in Toxicology|May 19, 2022
Application of Defined Approaches for Skin Sensitization to Agrochemical ProductsJudy Strickland, James Truax, Marco Corvaro, et al.
Cancer Chemotherapy and Pharmacology|October 26, 2010
Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumorsCarlos Castaneda, Kellen L Meadows, Roxanne Truax, et al.
Applied in Vitro Toxicology|January 17, 2023
Application of Defined Approaches to Assess Skin Sensitization Potency of Isothiazolinone CompoundsJudy Strickland, David G Allen, Dori Germolec, et al.
The American Journal of Pathology|September 28, 2006
Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodiesDeepak M Sampathu, Manuela Neumann, Linda K Kwong, et al.
Journal of the American Heart Association|February 24, 2021
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID-19Rohan Khera, Callahan Clark, Yuan Lu, et al.
Pageof 25